Structure-Activity Relationship of 1,4-Disubstituted Tetrazoles on Benzene and Biphenyl Systems: Synthesis, Antiproliferative Evaluation, and Molecular Docking Studies
Department
Chemistry
Advisor
Dr. Baker Jawabrah Al Hourani, PhD
Document Type
Poster
Start Date
2-26-2025 2:00 PM
End Date
2-26-2025 5:00 PM
Abstract
Tetrazole compounds, known for their nitrogen-rich heterocyclic structure, have demonstrated significant potential in medicinal chemistry, particularly as bioisosteres for carboxylate groups and as anticancer agents. This study explores the structure-activity relationship (SAR) of 1,4-disubstituted tetrazoles on benzene and biphenyl scaffolds, with an emphasis on steric bulk to enhance target binding and biological activity. The synthesized tetrazole derivatives were evaluated for their antiproliferative properties against cancer cell lines, providing insight into their therapeutic potential. Additionally, molecular docking studies were conducted to assess their ability to interact with key molecular targets, with a focus on active site blockage via steric hindrance. The integration of synthetic methodologies, biological screening, and computational modeling in this study contributes to the ongoing development of tetrazole-based chemotherapeutic agents.
Recommended Citation
Mueller, Riley, "Structure-Activity Relationship of 1,4-Disubstituted Tetrazoles on Benzene and Biphenyl Systems: Synthesis, Antiproliferative Evaluation, and Molecular Docking Studies" (2025). Day of Scholarship. 18.
https://spark.bethel.edu/dayofscholarship/spring2025/feb26/18
Structure-Activity Relationship of 1,4-Disubstituted Tetrazoles on Benzene and Biphenyl Systems: Synthesis, Antiproliferative Evaluation, and Molecular Docking Studies
Tetrazole compounds, known for their nitrogen-rich heterocyclic structure, have demonstrated significant potential in medicinal chemistry, particularly as bioisosteres for carboxylate groups and as anticancer agents. This study explores the structure-activity relationship (SAR) of 1,4-disubstituted tetrazoles on benzene and biphenyl scaffolds, with an emphasis on steric bulk to enhance target binding and biological activity. The synthesized tetrazole derivatives were evaluated for their antiproliferative properties against cancer cell lines, providing insight into their therapeutic potential. Additionally, molecular docking studies were conducted to assess their ability to interact with key molecular targets, with a focus on active site blockage via steric hindrance. The integration of synthetic methodologies, biological screening, and computational modeling in this study contributes to the ongoing development of tetrazole-based chemotherapeutic agents.
